Health Care Deal News- August 6, 2012

 

Brought to you by www.DealSearchOnline.com
 

August 6, 2012 Issue:

 

  1. Recent Health Care M&A Deals 
  2. Spotlight on: Pharmaceuticals
  3. Spotlight on: Venture Capital
  4. Conference Calendar

Recent Health Care M&A Deals

BIOTECHNOLOGY

Acquirer

Target

Price

Metabolon

Lipomics Technologies

N/A

Stemgent

Asterand’s Human Tissue Business

$9.0 million

E-HEALTH

Acquirer

Target

Price

Accenture

Octagon Research Solutions

N/A

Roper Industries, Inc.

Sunquest Information Systems, Inc.

$1.42 billion

MEDICAL DEVICES

Acquirer

Target

Price

Haemonetics Corporation

Pall Corporation’s Transfusion Medicine Business

$550.0 million

 

 

 

 

Is Your Company a Power User of Merger and Acquisition Data?
Drive the price of data down to less than 3 cents per item. Call 1-800-248-1668 to learn about our frequency discounts. Go to http://www.dealsearchonline.com, an easy-to-use, award-winning database. This specialized database is an essential 24/7 source for details on health care mergers and acquisitions covering 13 sectors. With approximately 20,000 records of investments and contact names (including e-mail addresses), you’ll get the information you need to make an informed decision any time of the day or night. Call 1-800-248-1668 to learn about our frequency discounts.

 

Spotlight on: Pharmaceuticals
This past month produced several acquisitions in the pharmaceutical industry. Our transaction table includes a brief summary of each deal and purchase details.....Read more
 

 

How can we serve you better? Complete our brief survey for a chance to win $250 from AMEX!
What is most important to your business? Is there something you would like to see in one of our publications? We are dedicated to being an integral part of keeping your business ahead of the competition. We would love to hear from you. Fill out our brief publications survey and you will be entered for a chance to win one of two $250 American Express gift cards! http://www.levinassociates.com/pubsurvey

 

Spotlight on: Venture Capital
In the venture capital arena, Third Rock Ventures launched Global Blood Therapeutics with a $40.7 million Series A financing.  Its lead program focuses on Sickle Cell Disease SCD), one of the earliest rare genetic diseases  defined on a molecular basis........Read more

 
Conference Calendar...Click here to see more